| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.31 | 0.04 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |